Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improvement of Transmural Inflammation With Adalimumab Versus Immunomodulator Maintenance Therapy in Pediatric Crohn's Disease: Single-Center Prospective Evaluation Using the Pediatric Inflammatory Crohn's Magnetic Resonance Enterography Index.
Scarallo L, McKay HE, Schneider R, Ricciuto A, Walters TD, Greer MC, Griffiths AM, Church PC. Scarallo L, et al. Among authors: ricciuto a. Inflamm Bowel Dis. 2024 Dec 17:izae227. doi: 10.1093/ibd/izae227. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 39688854
Response from the Canadian Children Inflammatory Bowel Disease Network to the US Food and Drug Administration Draft Guidance for Industry on pediatric inflammatory bowel disease: developing drugs for treatment.
Wine E, deBruyn J, Crowley E, Griffiths AM; Canadian Children IBD Network. Wine E, et al. J Can Assoc Gastroenterol. 2024 Oct 12;7(6):397-398. doi: 10.1093/jcag/gwae034. eCollection 2024 Dec. J Can Assoc Gastroenterol. 2024. PMID: 39679099 Free PMC article. No abstract available.
Body Surface Area-Based Dosing of Infliximab is Superior to Standard Weight-Based Dosing in Children With Very Early Onset Inflammatory Bowel Disease.
Stallard L, Frost K, Frost N, Scarallo L, Benchimol EI, Walters TD, Church PC, Griffiths AM, Muise AM, Ricciuto A. Stallard L, et al. Among authors: ricciuto a. Gastro Hep Adv. 2023 Nov 18;3(2):215-220. doi: 10.1016/j.gastha.2023.11.004. eCollection 2024. Gastro Hep Adv. 2023. PMID: 39129953 Free PMC article.
Landscape of TPMT and NUDT15 Pharmacogenetic Variation in a Cohort of Canadian Pediatric Inflammatory Bowel Disease Patients.
Kennedy AM, Griffiths AM, Muise AM, Walters TD, Ricciuto A, Huynh HQ, Wine E, Jacobson K, Lawrence S, Carman N, Mack DR, deBruyn JC, Otley AR, Deslandres C, El-Matary W, Zachos M, Benchimol EI, Critch J, Schneider R, Crowley E, Li M, Warner N, McGovern DPB, Li D, Haritunians T, Rudin S, Cohn I. Kennedy AM, et al. Among authors: ricciuto a. Inflamm Bowel Dis. 2024 Dec 5;30(12):2418-2427. doi: 10.1093/ibd/izae109. Inflamm Bowel Dis. 2024. PMID: 38788739 Free PMC article.
Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium.
Ricciuto A, Liu K, El-Matary W, Amin M, Amir AZ, Aumar M, Auth M, Di Guglielmo MD, Druve Tavares Fagundes E, Rodrigues Ferreira A, Furuya KN, Gupta N, Guthery S, Horslen SP, Jensen K, Kamath BM, Kerkar N, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Mack C, Martinez M, Montano-Loza A, Ovchinsky N, Papadopoulou A, Perito ER, Sathya P, Schwarz KB, Shah U, Shteyer E, Soufi N, Stevens JP, Taylor A, Tessier ME, Valentino P, Woynarowski M, Deneau M; Pediatric PSC Consortium. Ricciuto A, et al. Aliment Pharmacol Ther. 2024 May;59(10):1236-1247. doi: 10.1111/apt.17936. Epub 2024 Mar 10. Aliment Pharmacol Ther. 2024. PMID: 38462727
Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver.
Andrews TS, Nakib D, Perciani CT, Ma XZ, Liu L, Winter E, Camat D, Chung SW, Lumanto P, Manuel J, Mangroo S, Hansen B, Arpinder B, Thoeni C, Sayed B, Feld J, Gehring A, Gulamhusein A, Hirschfield GM, Ricciuto A, Bader GD, McGilvray ID, MacParland S. Andrews TS, et al. Among authors: ricciuto a. J Hepatol. 2024 May;80(5):730-743. doi: 10.1016/j.jhep.2023.12.023. Epub 2024 Jan 8. J Hepatol. 2024. PMID: 38199298 Free article.
Adalimumab vs Infliximab in Luminal Pediatric Crohn's Disease: Comparable Outcomes in a Prospective Multicenter Cohort Study.
deBruyn JC, Huynh HQ, Griffiths AM, Jacobson K, Mack D, Deslandres C, El-Matary W, Otley AR, Church PC, Lawrence S, Wine E, Sherlock M, Critch J, Benchimol EI, Jantchou P, Rashid M, Carroll MW, Bax K, Ricciuto A, Carman N, Walters TD; Canadian Children IBD Network. deBruyn JC, et al. Among authors: ricciuto a. Am J Gastroenterol. 2024 Mar 1;119(3):565-575. doi: 10.14309/ajg.0000000000002552. Epub 2023 Oct 3. Am J Gastroenterol. 2024. PMID: 37787642
Outcomes Following Acute Severe Colitis at Initial Presentation: A Multi-centre, Prospective, Paediatric Cohort Study.
Dhaliwal J, Tertigas D, Carman N, Lawrence S, Debruyn JC, Wine E, Church PC, Huynh HQ, Rashid M, El-Matary W, Deslandres C, Critch J, Ricciuto A, Carroll MW, Benchimol EI, Muise A, Jacobson K, Otley AR, Vallance B, Mack DR, Walters TD, Surette MG, Griffiths AM. Dhaliwal J, et al. Among authors: ricciuto a. J Crohns Colitis. 2024 Feb 26;18(2):233-245. doi: 10.1093/ecco-jcc/jjad143. J Crohns Colitis. 2024. PMID: 37602969 Free PMC article.
58 results